Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: A case series

Catecholamine-resistant postoperative vasoplegic syndrome (PVS) lacks effective treatment modalities. Synthetic angiotensin II was recently approved for the treatment of vasodilatory shock; however, its use in PVS is not well described. We report outcomes in six patients receiving angiotensin II for...

Full description

Bibliographic Details
Main Authors: Enfield, K.B (Author), Hulse, M.C (Author), Konkol, S.B (Author), Mihalek, A.D (Author), Morrisette, M.J (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
Online Access:View Fulltext in Publisher